A record 323 drug shortages in 2024, caused mainly by manufacturing and quality issues, affected at least half a million patients.

Drug shortages, tracked since 2001, currently include 32 chemotherapy drugs and central nervous system stimulants.

The average shortage affects over half a million patients and lasts over two years for more than half of treatments.

Supply chain gaps, downtime, and high demand contribute to drug shortages, highlighting the need for improved production and management processes.

Healthcare systems have implemented coping mechanisms like alternative drugs, rationing, and prioritizing patients by urgent need.

The European Union has proposed measures to address drug shortages, including a solidarity mechanism, early warning system, and fast-tracked approvals for alternative suppliers.

The EU encourages joint drug procurement among member states.

The FDA is working to increase drug supply and reduce shortages in the US.

The FDA allows importation of certain overseas drugs to mitigate shortages.

Drug shortages cost healthcare facilities at least $359 million per year.

The pharmaceutical industry's lack of transparency hinders the response to drug shortages, requiring the FDA to have more access to information.

Manufacturers should be more transparent and diversify their supply chains to address drug shortages.

Data analytics, machine learning, and labeling systems can help predict, prevent, and track drug shortages in real-time.

The Ministry of Health has proposed a strategy to address medication shortages, including five coping mechanisms.

The government has implemented a drug price adjustment mechanism and introduced alternative drugs at the same or lower price.

The FDA and Central Health Insurance Administration have implemented measures to increase drug supply and manage healthcare costs.

The government plans to establish a permanent drug shortage center and review health insurance drug pricing to boost domestic generic drug production.

The Ministry of Health reviews and prioritizes the life-saving medicines list to address shortages.

The Minister announced a reconsideration of drug policy, including a review of the basic medicines list based on scientific standards and budget allocations.

The government has implemented a contracting and transport mechanism for medicines, subject to auditing and practical standards.

The Ministry prioritizes the national medicine industry to increase reliance on local products.

The National Health Commission has improved the shortage drug classification system, with public medical institutions reporting shortages to the State Medical Insurance Bureau.

The State Medical Insurance Bureau and National Drug Administration track drug shortages and production.

The government monitors drug production and promotes review of shortage drug lists.

The State Medical Insurance Bureau and Ministry of Industry work to address drug shortages through online procurement and centralized production bases.

The government enforces laws against illegal pharmaceutical practices through the General Administration of Market Supervision.

The National Health Commission and State Council address rural drug shortages and epidemic prevention.

The daily dispatch system and supportive policies help expand drug supply to rural areas.

Supply and demand docking is strengthened to address shortages through targeted local procurement.

Traditional Chinese medicine helps alleviate shortages and improve drug supply.

The drug shortage problem is improving with increased production and China's planned drug shortage center.

The FDA and NHIA take steps to address production and pricing of medicines.

The government sets up an alternative drug information platform and orders manufacturers to resume production.

The regulatory body and government take steps to increase production and monitor raw material imports.

In Taiwan, the Ministry of Health and Welfare and the Food and Drug Administration address drug shortages.

The National Health Insurance Administration and the Drug Market Monitoring System help respond to and monitor drug shortages and supply.

The government improves medical laws and ensures patient privacy.

Taiwan faces an ultra-aging society, prompting the government to amend regulations and improve medical services.

The Ministry of Health plans to establish a "shortage of drugs center" in collaboration with the medical community and companies.

Low drug prices reduce pharmaceutical companies' production willingness, prompting a proposed "floor price" to protect their basic profits.

Taiwan sets a floor price for prescription drugs and reviews the Drug Expenses Target System.

Taiwan has 131 necessary medicines out of stock despite government efforts to maintain a stable supply.

The US FDA has a Drug Deficiency Monitoring Center, but Taiwan's Ministry of Health and Welfare does not.

The Kuomintang demands a "Drug Deficiency Monitoring Center" and the Minister convened a meeting on the issue.

Taiwan's health insurance system drives down drug prices, causing shortages, and the budget is planned to be slashed.

Taiwan is often prioritized last by international pharmaceutical companies due to its low prices and lack of government funding to address drug shortages.

Community pharmacies have formed a "mutual aid association" to address medication shortages, underscoring the need for government support.

The World Health Organization (WHO) promotes pharmaceutical quality and combats drug smuggling and counterfeiting to help address global medication shortages.

WHO ensures drug security and cooperates with local health authorities to promote good medicine provision.

International cooperation and knowledge sharing are essential in addressing global medication shortages, as emphasized by the WHO.

The WHO warns of a global injection shortage of up to 2 billion units by next year, threatening vaccination efforts.

The COVID-19 pandemic has caused a worldwide injection shortage, with 7.25 billion coronavirus vaccine doses given globally.

The WHO addresses medicine shortages and has a plan for traditional medicine, including knowledge sharing and a global repository.

International organizations like the WHO can provide technical expertise to countries facing shortages, as seen in Libya's blood bag shortage.

The WHO has found that twenty-eight of thirty-five countries it monitors face penicillin-type drug shortages.

The WHO facilitates global cooperation to address medication shortages and provide access to healthcare services.

The WHO helps countries secure health sector needs through international cooperation, as seen in Syria.

The WHO provides training and support to national drug authorities to promote pharmaceutical sector development.

International cooperation is necessary for equitable vaccine distribution and to address medication shortages, including preventing syringe reuse due to contamination risks.

The WHO supports countries in producing safe medicines and encourages international solidarity in research and development.

The WHO provides technical support and promotes international cooperation in the pharmaceutical sector.

The WHO cooperates with national drug authorities, such as Egypt's, to address global health issues.

The WHO stresses global vaccine sharing and international cooperation to combat COVID-19 and medication shortages.

The WHO can facilitate international cooperation in traditional medicine to promote well-being and sustainable development.

The Ministry of Health and Welfare created a center to monitor and respond to drug shortages in real-time.

The Ministry of Health and Welfare will establish domestic production supply chains, aided by a reporting system for drug shortages to be operational by April 2023.

A dedicated person and a drug price adjustment mechanism with alternative lower-cost drugs are available to help with unmet prescription costs.

A record 323 drug shortages in 2024, caused mainly by manufacturing and quality issues, affected at least half a million patients.

Title:

Content: General Supervision
Elham Aboul Fath
Editor-in-Chief
Thank you for your patience.
General Supervision
Elham Aboul Fath
Editor-in-Chief
Thank you for your patience.
An Unexpected Catastrophe in the World ’ s Largest Country: The Complete Story of U.S. Drug Shortages
The deficit is at a record level.
According to data from the American Society of Health System Pharmacists and the University of Utah Drug Information Service, organizations began tracking drug shortages for the first time in 2001. Steady since 2021 – now reaching a record high of 323 drugs in the first three months of 2024.
Paul Abramowitz, CEO of the American Society of Health System Pharmacists, wrote in a blog post on Thursday: “It ’ s been a long time to end drug shortages, ” and wrote:“ All drug classes are vulnerable to shortages, some of the most worrisome shortages include sterile injectable generic drugs, including cancer chemotherapy drugs and emergency drugs stored in hospital vans and procedural areas. It is dangerous for doctors and patients. ”
In addition to the 32 chemotherapy drugs that are deficient, the five categories of drugs with the greatest deficiency include central nervous system stimulants, antimicrobials, hormonal agents, and intravenous fluids. [1] The Drug Deficiency Database maintained by the American Society of Health System Pharmacists and the University of Utah is based on voluntary reports from practitioners, patients, and others that have been confirmed by manufacturers. The U.S. drug is in short supply, because it captures broader effects on service providers and patients.
The crisis has lasted a year and a half.
More than half of the treatment shortages have lasted for more than two years, according to an analysis by health consultancy IQVIA, and the average shortage affects at least half a million patients, many of them elderly, according to the US Office of Health and Human Services under the Assistant Secretary for Planning and Evaluation, which shared its analysis with Congress in May.
Growing demand can play a role in drug shortages, as with the recent shortage of weight-loss drugs, but often manufacturing and quality problems, such as supply chain gaps and downtime, are the root cause. And varied.
But the American Society of Health System Pharmacists has “serious concerns ” about parts of this proposal, especially financial sanctions imposed on hospitals that lack the resources to comply with the recommendations, Abramowitz wrote:“ We all know that managing shortages is not enough and is not a sustainable solution to the worsening crisis, and there is still a lot of work to be done at the federal level to fix the root causes of drug shortages. ”
Why Shortage Occurs
Shortages can be caused by high demand, as with the recent shortage of weight-loss drugs, but this is not usually the main problem.
The FDA also blames manufacturing and quality problems, supply chain gaps, and downtime, and Dr. Emily Tucker, a drug shortage expert and an assistant professor of industrial engineering at Clemson University, says that when there is an indication of shortages, large health systems often also proactively place large orders, adding to the system ’ s stress.
“I don ’ t blame anyone.
“When I talk to all the stakeholders – whether it ’ s wholesalers, manufacturers, or the government – everyone wants this problem to end, ” she said.
Lack of transparency
Dr. Julie Grallo, chief medical officer and executive vice president of the American Society of Clinical Oncology, told the House Committee earlier that the shortage puts providers in a terrible position: “The drug shortage crisis is forcing providers to make impossible choices, and it is also hindering the development of new drugs. Health drugs are purchased only on a price basis, and manufacturers do not have to disclose the source of their acquisition of the ingredients.
The shortage of this generic chemical drug came due to the closure of one factory in India that manufactures the active ingredient after a surprise FDA inspection found “significant quality issues, ” says Jarallo:“ We didn ’ t know, and there was no transparency regarding the company ’ s supply of the majority of active pharmaceutical ingredients to all manufacturers across the board.
Knowing this in advance, we could have responded much faster, ” Dr. Steven Schundlemeyer, director of the PRIME Institute of the University of Minnesota School of Pharmacy, which focuses on economic and management issues, told the committee that as with defense contractors in the United States, New Zealand requires manufacturers to disclose their suppliers, and that information is required.
Easily accessible in the database.
Related Topics

Drug shortages, tracked since 2001, currently include 32 chemotherapy drugs and central nervous system stimulants.

The average shortage affects over half a million patients and lasts over two years for more than half of treatments.

Supply chain gaps, downtime, and high demand contribute to drug shortages, highlighting the need for improved production and management processes.

Healthcare systems have implemented coping mechanisms like alternative drugs, rationing, and prioritizing patients by urgent need.

Title:

Content: The lack of medicine continues to burn!
The Ministry of Health and Welfare has proposed a short, medium and long-term strategy to deal with the current 5 coping mechanisms.
Journalist Yen Zhenzhen / Taipei Report
According to the Ministry of Health and Welfare, the shortage of drugs is not a single factor, but includes supply problems, manufacturing problems, clinical demand factors, uneven distribution of drugs, drug use habits and drug prices. In addition to dealing with the relatively high clinical demand items, it is properly allocated to all levels of medical institutions and pharmacies to fully meet the needs of clinical end-use drugs.
This is an advertisement, please continue reading.
In the face of the shortage of drugs, Wang said, the existing health insurance uses five major coping mechanisms, including 1, a single processing window, a dedicated person to help deal with the problem of drug purchase, and contact the Food and Drug Administration to put relevant information on the website of the NHI. (4) Drug price adjustment mechanism that does not meet the cost can be re-checked according to the way of raising the price of special drugs; (5) Alternative drugs can still declare the cost, if they are not irreplaceable, they can be replaced at the same price or lower than the original prescription drug price.
In addition, Wang pointed out that in the face of the international epidemic, the Russian-Ukrainian war, and labor shortage, drug shortage is a problem facing all countries. In order to strengthen the stable supply mechanism of drugs in China, the Ministry of Health and Welfare continues to actively respond to the short-term strategy to solve the problem of drug shortage. The Food and Drug Administration (FDA) and the pharmaceutical industry have made every effort to actively arrange production lines, strive for early import, increase production / import quantity, and properly distribute to all levels of medical institutions and pharmacies to fully meet the demand for clinical end use drugs.
In addition, to properly handle the issue of drug price adjustment, the Central Health Insurance Administration of the Ministry of Health and Welfare intends to implement the "Universal Health Insurance Cost Distribution Target System (DET)" in April this year, which will adjust the number of drug prices and adjust the quota in a suitable manner, taking into account factors such as the epidemic, the Russian-Ukrainian war and inflation.
In terms of medium-term strategy, Wang said that he will establish a permanent drug shortage treatment center and optimize drug supply information transmission.
In order to speed up the handling of drug shortage incidents, we will adopt dedicated personnel and cross-departmental cooperation to develop drug shortage prevention policies to prevent drug shortage in advance, strengthen cross-departmental data integration and proactive monitoring to detect drug shortage incidents at an early stage, and intervene early through cross-departmental cooperation to stabilize drug supply.
At the same time, the Food and Drug Administration (FDA) continues to disseminate drug supply and alternative drug information through various channels. In addition to posting on the “Drug Supply Information Platform ”, the FDA will notify medical institutions and pharmacies through VPN, and weekly letters to relevant medical associations and public associations to inform members. Management system.
In the long-term strategy section, it includes reviewing the current health insurance drug pricing policy and encouraging the production of domestically manufactured generic drugs.
Wang Bi-sheng pointed out that in the review of the current health insurance drug price policy, including the development of the price protection of indicative drugs, drug price review for the lack of drugs; start the review of drug expenditure target (DET), plan the establishment of a risk control mechanism, plan the national unified procurement trial plan; comprehensively review the health insurance drug price policy, give an appropriate price protection mechanism for necessary drugs, and also target the patent period. To encourage the production of domestic manufacturers to ensure that when there is a shortage of original pharmaceutical products, there are domestic famous drugs to respond.
Wang also stressed that the Food and Drug Administration has set up a "Drug Supply Information Platform" (https: / / dsms.fda.gov.tw /), reporting hotline (02) 27878249. If medical institutions and pharmacies have any shortage of drugs, they can go to the platform for enquiry or notification, and the department will deal with it immediately.
This is an advertisement, please continue reading.

The European Union has proposed measures to address drug shortages, including a solidarity mechanism, early warning system, and fast-tracked approvals for alternative suppliers.

Title:

Content: Brussels is planning for EU countries to share vital medicines and take emergency measures to avoid a repeat of shortages that hit the bloc a year ago.

The European Commission is proposing a “voluntary solidarity mechanism” requested by France and Germany and an early warning system flagging when drugs become scarce, according to draft proposals seen by the Financial Times. If insufficient donors come forward, EU capitals will be allowed to tap into an EU-funded stockpile set up during the Covid-19 pandemic and take other emergency measures.

In December and January western countries suffered a shortage of antibiotics including penicillin and amoxicillin, and painkillers such as paracetamol, especially in medicines used by children.

Among the emergency measures floated to prevent a repeat of that crisis, the commission could allow the extension of a drug’s shelf life, fast track approvals of alternative suppliers and support production increases.

Brussels will also encourage joint procurement of drugs from 2024 and medicine swaps with countries in the southern hemisphere, where peak winter demand happens at a different time.

The commission will draw up guidance for national stockpiles in 2024 and establish a Critical Medicines Alliance bringing governments, industry and civil society together. The commission declined to comment.

Three-quarters of countries reported a worsening of drug shortages in 2022, according to an industry survey. EU manufacturing is heavily reliant on imported active pharmaceutical ingredients from China and India.

Rising demand and disruption to supply chains have been compounded by inflation hitting the production of generic drugs, which typically sell at much lower prices than branded versions.

France has been actively encouraging the reshoring of basic medicine supply, with a giant paracetamol factory set to open in the country next year.

The EU is discussing whether to provide more funding for domestic production.

The commission’s proposal is scheduled to be approved on October 25 and could still change. Initially non-binding, it could lead to a Critical Medicines Act, with Brussels drawing up a list of vital medicines by year-end.

The commission also urges member states and the European parliament to approve its overhaul of pharmaceutical legislation, put forward in April. It includes plans to take control of drug production in the event of a public health emergency, a requirement for stockholders to inform Brussels of supply levels and for manufacturers to give early warnings of shortages.

An analysis by the European Medicines Agency and the commission found that unless there is unexpected demand the EU should avoid an antibiotics shortage this year.

“The information available today suggests that — if demand in the coming winter season does not differ significantly from the demand of recent years — the supply to the EU of key antibiotics seems to generally match demand,” the analysis said.

“However, this depends strongly on the compliance of industry with their legal obligations to ensure supply and their ability to adapt.”

Copyright The Financial Times Limited 2023. All rights reserved.
Reuse this content (opens in new window) CommentsJump to comments section

Follow the topics in this article

The EU encourages joint drug procurement among member states.

The FDA is working to increase drug supply and reduce shortages in the US.

The FDA allows importation of certain overseas drugs to mitigate shortages.

Title:

Content: As drug shortage list grows, many hospitals face tough decisions on rationing care

More than half of hospital pharmacists are reporting a critical shortage of chemotherapy drugs and nearly all are reporting overall medicine supply gaps as prescription drug shortages near an all time high, according to a new survey.

Hospital pharmacists said drug shortages have forced 1 in 3 health systems to delay, cancel or ration care or switch to alternate drugs to continue to treat patients. And 99% are reporting some drug supply shortages, an American Society of Health-System Pharmacists survey of more than 1,000 pharmacists released Thursday found.

The organization reported shortages of 309 drugs, near the all-time high of 320 shortages in 2014. The scarcity of key drugs is prompting hospitals to find or substitute drugs and change treatment plans as needed.

“In some cases, there are no alternatives to the affected drugs, which puts patients at risk," ASHP Chief Executive Officer Paul W. Abramowitz said in a statement. "This issue requires quick action from Congress to address the underlying causes of shortages and ensure patients have the medications they need.”

Cancer drug shortages

In June, the Food and Drug Administration said it will temporarily allow overseas drug manufacturers to import some chemotherapy drugs.

The FDA allowed Qilu Pharmaceutical, a drug manufacturer in China, to import the injectable chemotherapy drug cisplatin in 50-milligram vials. Toronto pharmaceutical company Apotex Corp. will distribute the medication in the United States.

More than a dozen cancer drugs have been in shortage in recent months, including cisplatin and carboplatin, used to treat lung, breast, prostate and gynecologic cancers. The National Cancer Institute said cisplatin and similar drugs are prescribed for 10% to 20% of all cancer patients.

In June, the National Comprehensive Cancer Network released a survey of 27 academic cancer centers that found 93% reported shortages of carboplatin and 70% faced shortages of cisplatin.

When cancer hospitals face such shortages, they attempt to make sure there's enough medication for patients to finish the course of treatment, said Mike Ganio, ASHP's senior director of pharmacy practice and quality.

Cancer hospitals facing such shortages might change medications for new patients starting on chemotherapy, said Ganio, a former pharmacy manager at an academic cancer center.

"You try to keep that patient on the same regimen as much as you can, unless they're failing it for some reason, and then you would switch," Ganio said.

Steroids, hormonal drugs also in short supply

More than 1 in 5 hospital pharmacists also reported shortages for steroids, hormonal drugs and oral liquids such as lidocaine, ibuprofen and amoxicillin.

A smaller number of pharmacists said heart medications, emergency prefilled syringes and drugs used for intensive care unit patients were in short supply. Others reported shortages of attention deficit hyperactivity disorder medicines, antimicrobial drugs and injectable opioids.

In all, about two-thirds of pharmacists said the shortages were "moderately impactful," which means they are managing shortages but patients are affected.

Pharmacists are managing the shortages by offering therapeutic alternatives, buying different vial sizes or concentrations and rationing medicines.

This article originally appeared on USA TODAY: Survey: Drug shortages are widespread, hospitals ration care

Drug shortages cost healthcare facilities at least $359 million per year.

Title:

Content: Skip to content

Omnicell Announces Latest Advancements in Automation, Intelligence, and Technology …

Omnicell Announces Latest Advancements in Automation, Intelligence, and Technology …

Omnicell, Inc. (Nasdaq:OMCL), a leading provider of medication … It is estimated that drug shortages are costing facilities at least $359 million per year in … More than 50,000 institutional and retail pharmacies across North America …
See all stories on this topic

Nearly 75 per cent of Ontario doctors experienced burnout during pandemic, survey says …

Nearly 75 per cent of Ontario doctors experienced burnout during pandemic, survey says … as COVID-19 was first hitting North America – that saw 66 per cent of respondents report some level of … Dr. Adam Kassam, president of the OMA, said physician burnout has always been a problem, but it’s been …
See all stories on this topic

Health researchers report funder pressure to suppress results – Nature

These trials, published between 2007 and 2017, were cited in Cochrane reviews, which are considered the ‘gold-standard’ of evidence used to inform …
See all stories on this topic

Survey: nearly 75 per cent of Ontario doctors experienced burnout during pandemic – Toronto Star

Dr. Carolyn Snider felt a gamut of emotions while working in one of the busiest emergency rooms in Canada during the last 18 months of the …
See all stories on this topic

Asia-Pacific Over the Counter (OTC) Drugs Market 2021 Segmented by Product, Distribution …

North America currently holds the largest share in the market, due to the increasing expenditure in healthcare. Inclination of Pharmaceutical Companies …
See all stories on this topic

Published inSubstance Abuse

The pharmaceutical industry's lack of transparency hinders the response to drug shortages, requiring the FDA to have more access to information.

Title:

Content: Meitu
The first quarter of the United States serious drug shortage 323 drugs urgent cancer patients also have to be diverted and rationed!
CHU HENG NETWORK NEWS CENTER 2024-04-16 10: 42
According to the latest data from the American Society of Health System Pharmacists (ASHP) and the Utah Center for Drug Information Services, a total of 323 drugs in the United States were in severe shortages in the first quarter of this year, surpassing the record of 320 in 2014.
Among the drugs affected are the widely used diabetes drugs Ozempic and Mounjaro, the allergy treatment drug adrenaline, the common antibiotic amoxicillin for children, chemotherapy drugs and injections commonly used in hospitals in intensive care.
ASHP CEO Paul Abramowitz said in a statement that almost all categories of drugs are facing shortages, with non-patented sterile injectable drugs, including cancer chemotherapy drugs, and emergency drugs stored in hospital emergency vans and operating areas, the shortage of such drugs is the most worrying.
According to the American Cancer Society, chemotherapy is one of the top five drugs most affected by the shortage, which threatens to have a devastating impact on patients, and some hospitals and clinics say doctors have had to divert patients to ration their medications because of a shortage of some chemotherapy drugs.
In addition, ASHP noted that the continued nationwide shortage of ADHD drugs is “a problem for clinicians and patients. ”
The shortage of popular drugs is even more acute, with Mounjaro, the diabetes drug known as the “slimming pill ”, already in dire straits.
In response, Lilly said that the “unprecedented surge in demand ” for Mounjaro and its similar drug Zepbound has led to a shortage in the market, which the company is struggling to cope with.
Lilly is ramping up investments to boost production at Mounjaro and Zepbound in the second half of 2024.
The company said it expects intermittent supply disruptions in the near term due to unprecedented demand.
How to cure the drug shortage
The last major “drug shortage ” in U.S. history occurred in 2014, and it has only been alleviated in the years since.
Since 2021, the drug shortage situation seems to be increasing, and scholars in the field of medical health and economics in the United States believe that the reason for most drug shortages in the United States is the fragmentation of the drug supply chain.
The White House this month proposed spending between $3.26 billion and $5.11 billion over the next decade to help address the nation ’ s drug shortage.
The bill requires approval and funding from the U.S. Congress.
U.S. researchers and policymakers believe that a complete solution to the “drug shortage ” may require changes to the business model of the U.S. pharmaceutical industry, including measures to increase the price of generic drugs to attract more drug manufacturers.
Policymakers recommend giving the FDA more power to access more information about drug shortages and impending shortages.
Currently, the FDA relies primarily on phone calls to manufacturers asking if they can increase their supply to understand the situation.
The American Society of Health System Pharmacists said it is working with the federal government to advise the government on measures to address the drug shortage, including that Congress should require manufacturers to be more transparent on any supply chain issues and encourage more diversity in supply chains.
According to Abramowitz, “The federal government still has a lot of work to do to fundamentally address drug shortages, and the American Society of Health System Pharmacists will continue to engage regularly with policymakers to guide them in drafting and passing new legislation to address drug shortages and continue to advocate vigorously for proven solutions on behalf of our members. ”

Manufacturers should be more transparent and diversify their supply chains to address drug shortages.

Data analytics, machine learning, and labeling systems can help predict, prevent, and track drug shortages in real-time.

Title:

Content: The Ministry of Health told what they did to prevent a shortage of drugs
The head of the Ministry held a meeting with representatives of pharmaceutical companies
The head of the Ministry of health Mikhail Murashko said that the government has made decisions that will help to avoid a shortage of drugs.
He said this at a meeting with representatives of pharmaceutical companies, which took place on April 18.
In particular, an advance of 240 billion rubles was made within the framework of compulsory medical insurance, which is up to 80% of all expenses of medical organizations for drug provision, - the Minister of Health said. - This allows pharmaceutical manufacturers to clearly plan the production and supply of drugs.
Today, thanks to the labeling system, we see the movement of medicines, their remains in each region and the introduction into civilian circulation in real time.
This allows us to determine with high accuracy the positions at which subsequently reduced availability is possible, and to take the necessary measures in advance.
Murashko also noted that in the near future, the possibility of using data on the pharmaceutical substance previously included in the registration certificate of other drugs during the registration of a medicinal product will be worked out without the need for additional examinations.
This will simplify the registration process.
• LIKE0
• LAUGHT1
• SURPRISION0
• RIGHT0
• FURNITURE0
Did you see the typo?
Select a fragment and press Ctrl + Enter
� � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � �
� � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � �

The Ministry of Health has proposed a strategy to address medication shortages, including five coping mechanisms.

The government has implemented a drug price adjustment mechanism and introduced alternative drugs at the same or lower price.

The FDA and Central Health Insurance Administration have implemented measures to increase drug supply and manage healthcare costs.

The government plans to establish a permanent drug shortage center and review health insurance drug pricing to boost domestic generic drug production.

The Ministry of Health reviews and prioritizes the life-saving medicines list to address shortages.

Title:

Content: Health: Revisiting the list of life-saving medicines
BAGHDAD – Bright News
The Ministry of Health revealed on Sunday the review of the list of life-saving medicines, confirming the guidance to fully secure it and fill the shortage.
A spokesman for the ministry, Saif al-Badr, said in a statement to the (range), that "the Ministry of Health has set one of its priorities a plan to bridge the transfer of medicines."
Al-Badr added that "Minister of Health Saleh al-Hasnawi announced from the first day of assuming his duties to reconsider the work of drug policy."
He pointed out that "the list of basic medicines that include life-saving drugs will be reviewed according to scientific standards and the requirements of Iraqi health institutions, and in line with meeting the needs at various levels of health care."
Al-Bader explained that "everyone is aware of the existence of loopholes that cause a shortage of some medicines; but the situation at the moment is much better than the previous stage."
He pointed out that "the Minister of Health confirmed the budget for the current year will include standard allocations to the Ministry of Health to provide basic medicines, which will be reflected during the coming period on the services provided to the citizen."
Al-Badr continues, "The mechanism of contracting and the details of transport and distribution need time; but all indicators confirm the acceleration of the pace of the provision of medicines and medical supplies, especially basic ones, and chronic gynecological diseases."
He pointed out that "the provision of medicines and medical supplies is subject to practical standards and control auditing, and the priority of the national industry, whether from the government or private sector, but the product must be in line with the standards approved by the Ministry of Health."
Al-Bader talked about "the Ministry of Health's tendency to increase reliance on the local industry, which provides financial amounts and processing and to ensure the speed of processing and support for the national product."
Disclaimer: All published articles represent the opinion of their authors only
Read our Privacy Policy by clicking here
By continuing to use the site, you agree to the use of cookies.
more information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible.
If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Close

The Minister announced a reconsideration of drug policy, including a review of the basic medicines list based on scientific standards and budget allocations.

The government has implemented a contracting and transport mechanism for medicines, subject to auditing and practical standards.

The Ministry prioritizes the national medicine industry to increase reliance on local products.

The National Health Commission has improved the shortage drug classification system, with public medical institutions reporting shortages to the State Medical Insurance Bureau.

Title:

Content: 【 Printing 】
2023 shortage of drugs reported information has been fully dealt with
Related LINKS http: / / www.CRNT.com 2024-03-14 15: 33: 32
Beijing, March 14 / Xinhua News Agency reported that the reporter learned from the National Health and Health Commission on the 13th, the national, provincial, municipal and county four shortage drug classification system gradually improved and effective operation, 2023 shortage drug reporting information has been fully addressed, and the temporary import work of clinically urgent drugs is done.
It is understood that in the near future, the national and provincial shortage of drug supply guarantee work will discuss the mechanism of various units to ensure the supply of stable prices as the focus, and continue to improve the classification of shortage of drugs to deal with the ability to deal with, multi-dimensional improvement of shortage of drug information monitoring.
The National Health and Health Commission relies on the national public medical and health institutions shortage of drug information direct reporting system and other monitoring conditions to carry out monitoring and early warning and regular reporting.
The State Medical Insurance Bureau continuously monitors the national shortage list of drugs and clinically necessary drugs that are vulnerable to shortage, focusing on the abnormal high prices and distribution data of the listed drugs.
The National Drug Administration continues to collect information on the production supply and shutdown reports of shortage of pharmaceutical products.
The Ministry of Industry and Information Technology relies on the shortage drug production supply monitoring and early warning platform to carry out dynamic monitoring and analysis.
The Ministry of Commerce organized some large pharmaceutical wholesale and retail enterprises to pay close attention to the supply and demand situation of pharmaceutical products.
At the same time, the whole chain guarantees the stable supply of shortage drugs.
The National Drug Administration continues to promote the review and approval of national shortage drug list varieties, and carries out the basic information labeling and data management of shortage drugs.
The State Medical and Health Insurance Bureau fully implements the policy of online procurement of shortage drugs, and explores the centralized procurement of shortage drugs.
The Ministry of Industry and Information Technology continues to support the construction of centralized production bases for small varieties of drugs, and establish regular shortages of drugs at the central and local levels.
The Ministry of Ecology and Environment takes flexible enforcement action to help enterprises rectify the situation in a timely manner if the environment of the enterprises involved in the production of pharmaceutical raw materials or preparations violates the law.
The SASAC of the State Council continues to promote state-owned enterprises to fulfill their social responsibilities in the supply of shortage drugs and play the function of "cistern".
The National Post Office continues to promote the construction of a comprehensive postal service platform, supporting the postal group to give full play to its network advantages and continuously improve its medical distribution service capabilities.
In addition, strengthen the enforcement of illegal acts.
The General Administration of Market Supervision investigates and punishes illegal acts such as monopoly in the field of pharmaceutical products according to law, and plays a warning and education role in major typical cases.
The General Administration of Taxation further increased the investigation and punishment of tax violations by some pharmaceutical enterprises, and standardized the tax order in the pharmaceutical field.
According to the clues of the problem and illegal facts, the National Medical Insurance Bureau talked about the relevant pharmaceutical companies to reduce the level of drug prices involved, and block the chain of benefits of manufacturing shortages and monopoly price increases.
【 Printing 】
Related News:

The State Medical Insurance Bureau and National Drug Administration track drug shortages and production.

The government monitors drug production and promotes review of shortage drug lists.

The State Medical Insurance Bureau and Ministry of Industry work to address drug shortages through online procurement and centralized production bases.

The government enforces laws against illegal pharmaceutical practices through the General Administration of Market Supervision.

The National Health Commission and State Council address rural drug shortages and epidemic prevention.

Title:

Content: Health · Life
How to solve the problem of drug shortage in rural areas?
National Health Commission response
January 07, 2023 17: 26 Source: People 's Daily Online
Beijing, January 7 (Reporter Yan Yan Yan) Today, the joint prevention and control mechanism of the State Council held a press conference to introduce the situation of epidemic prevention and control in rural areas and answer questions from the media.
At the press conference, a reporter asked, recently, many township health centers and village health rooms have a shortage of drugs and other problems, how to properly solve?
Nie Chunlei, director of the grass-roots department of the National Health Commission, said that rural areas are the focus of epidemic prevention and control and are also weak links.
The joint prevention and control mechanism of the State Council has attached great importance to the prevention and control of the epidemic in rural areas and made a lot of arrangements for deployment.
There is a shortage of medicines and other medical supplies in rural areas, for three reasons: First, the production capacity of individual medicines is insufficient, and the supply is in short supply.
Second, the information between the supply and demand sides is not smooth.
Third, logistics reasons, some purchased drugs can not be delivered in time, resulting in a shortage of drugs.
In response to the shortage of drugs, the state has taken a series of measures, Nie Chunlei said. First, the material support group of the joint prevention and control mechanism of the State Council has established a daily dispatch system to coordinate the daily dispatch of drugs and other key medical supplies.
According to the development of the epidemic, priority is given to medical institutions in rural areas, especially in rural areas.
For some drugs that are in short supply, those with insufficient production capacity, actively coordinate and expand production capacity.
Relevant departments have formulated policies to support relevant enterprises to expand production capacity, mobilize the enthusiasm of enterprises, and work overtime to produce relevant drugs.
The second is to strengthen supply and demand docking.
Rural areas have a wide range of points and long supply chains, and if the docking of supply and demand is not smooth, the problems reflected by the grassroots may not be timely feedback.
Local governments are encouraged to focus on procurement.
All localities should strengthen the docking of supply and demand through material support groups to solve the shortage of medicines in a timely manner.
Third, adhere to the combination of Chinese and Western medicine, rational selection of Western medicine, Chinese patent medicine and traditional Chinese medicine decoction.
Local governments, especially in rural areas, should be encouraged to give full play to the characteristics of rural areas, make full use of traditional Chinese medicines, alleviate the problem of insufficient medicines, and reduce the pressure on grass-roots medical care
Nie Chunlei said: "From the current monitoring situation, the shortage of medical supplies is more prominent, but recently with the development of the epidemic and the growth of drug production capacity in various localities, the coordination of material support groups and logistics is smooth, and the local government Strengthen the organization, the problem of drug shortage is gradually improving.
(Editor: Yang Di, Gao Lei)
Related News

The daily dispatch system and supportive policies help expand drug supply to rural areas.

Supply and demand docking is strengthened to address shortages through targeted local procurement.

Traditional Chinese medicine helps alleviate shortages and improve drug supply.

The drug shortage problem is improving with increased production and China's planned drug shortage center.

Title:

Content: China 's shortage of drugs "Chinese and Western drugs are out of stock" Wang Bi-sheng: Establish a shortage center to strengthen the deployment of drugs
▲ Central Epidemic Command Center press conference. (Photo / Courtesy of Central Epidemic Command Center)
Journalist Yen Yun-chen / reporting from Taipei
The Ministry of Health and Welfare plans to set up a "drug shortage center" in accordance with the Ministry of Health and Welfare's directive. And...
Wang says that the short-term problem with the shortage of drugs is the lack of production, and some manufacturers have recently responded that production has been suspended due to the Chinese New Year, and the Food and Drug Administration has asked manufacturers to speed up their pace.
[Advertisement] Please continue reading...
Although the Food and Drug Administration originally had a shortage of drug platforms, Wang said that in the medium and long term, a larger platform was still needed to stream alternative drug information and scheduling, and the relevant instructions would be dealt with as soon as the minister explained them.
Finally, Wang Bi-sheng mentioned that this morning the National Health Insurance Administration has conducted relevant discussions on the price of certain medicines lacking medicines, and has also conducted monitoring on imported raw materials.
Share with friends:
※ This article is copyrighted and cannot be reproduced without permission. [ETtoday Copyright Notice]
Hot News
The best video
And more.
Hot News
Back to the top.

The FDA and NHIA take steps to address production and pricing of medicines.

The government sets up an alternative drug information platform and orders manufacturers to resume production.

The regulatory body and government take steps to increase production and monitor raw material imports.

In Taiwan, the Ministry of Health and Welfare and the Food and Drug Administration address drug shortages.

Title:

Content: Cai Ing-wen: Thanks for 8 years of support, the epidemic and the government work together
Journalist Chen Wei-uei / reporting from Taipei
President Tsai Ing-wen attended the Spring Wine Dinner of the National Federation of Pharmacists of the Republic of China (ROC) on the evening of today (25), saying that the Ministry of Health and Welfare, the Food and Drug Administration and the National Health Insurance Administration have actively responded to the shortage of drugs.
In the future, Taiwan will enter an ultra-aging society, medical treatment combined with technology will become the norm, and the government will continue to improve and amend laws and regulations in a timely manner, looking forward to improving medical services.
This is an advertisement, please continue reading.
Tsai Ing-wen said in her speech that this year, the All Federation of Pharmacists Association will soon reach its 44th anniversary, and the past presidents and supervisors are committed to fighting for the rights of pharmacists, and also let the Federation become a bridge for communication between the government and the industry, so that the government can hear the voice of the pharmaceutical industry and be closer to public opinion in policy.
She would like to thank President Huang Jinshun for his leadership over the past few years, as well as all the good friends of pharmacists to protect the health of the people of the country.
At the same time, she also wants to spend her old age, and wish everyone a happy and safe New Year.
In the past few years, in the face of the challenges of the epidemic, all pharmacists have worked hard to stand on the front line, not only to mobilize drugs, but also to help the government release masks and rapid screening tests.
Tsai Ing-wen said that in addition to going deep into the community and the Changshu Center, the Association also shares Taiwan's experience in epidemic prevention and public health with pharmaceutical organizations around the world, so that the world can see Taiwan, give full play to the spirit of "Taiwan Can Help," and contribute its own efforts to the world.
Tsai Ing-wen pointed out that the government knows that the world is facing a shortage of drugs in recent years, and has asked the Ministry of Health and Welfare, the Food and Drug Administration, and the National Health Insurance Administration to actively respond to the problem.
At present, the "Drug Market Monitoring System" has been launched. This system will strengthen the monitoring of the supply of pharmaceutical products in the middle market, so that the front-line pharmacists can query the inventory of pharmaceutical products more quickly and ensure the rights and interests of the public.
Tsai Ing-wen stressed that Taiwan's society is entering an ultra-old age, and in the case of fewer children, the medical needs for home care will continue to increase.
In the future, medical combined technology will become the norm, such as telemedicine services and smart medical services that have been opened up.
The government will also continue to improve and amend regulations in a timely manner to ensure information security and patient privacy, and improve medical services.
Finally, Tsai thanked everyone for their support during her eight-year term in office, which allowed Taiwan to “pass through and overcome the barriers. ”
During the 100-year pandemic, I would like to thank my friends and the government for their hard work, so that Taiwan's epidemic prevention performance has been recognized by the world, and so that the public can better understand the role of pharmacists in the national epidemic prevention and medical system.
This is an advertisement, please continue reading.

The National Health Insurance Administration and the Drug Market Monitoring System help respond to and monitor drug shortages and supply.

The government improves medical laws and ensures patient privacy.

Taiwan faces an ultra-aging society, prompting the government to amend regulations and improve medical services.

The Ministry of Health plans to establish a "shortage of drugs center" in collaboration with the medical community and companies.

Title:

Content: There is a shortage of Chinese and Western medicines in the country, and there is a shortage of Punacao, the antibiotic ammonicillin, the acid-making agent magnesium oxide, and so on.
At present, the Ministry of Health and Welfare plans to establish a "shortage of drugs center", and the National Health Insurance Administration also invited the medical community, pharmaceutical companies, etc., to meet, it is generally deduced that the price of drugs is low, the lack of profit incentives, resulting in a reduction in the production willingness of pharmaceutical companies, which directly affects the stable supply of drugs.
Cai Mingzhong, chairman of the Kuomintang Medical Committee, said that in order to solve this problem, Shi Chongliang, director of the National Health Insurance Administration, proposed to ensure the necessary "directive drugs", and should set a "floor price" according to the prescription drugs to protect the basic profits of the drugs and avoid impacting the market supply.
He observed that Taiwan's "prescription drugs" in the past 1 or 2 years have set a floor price (at least 2 yuan or 1.5 yuan), the results are good, such a model should be transplanted to the common needs of the public "indication of drugs" items, the same set of "floor prices", to improve the industry's production willingness, is indeed one of the necessary measures to avoid market shortage of drugs, should be supported.
On March 18, 2019, the National Health Insurance Administration issued a press release saying that since the second generation of health insurance is on the road, the "Drug Expenses Target System" (DET) has been piloted in accordance with the law. A small number of pharmaceutical companies claim that the price of health insurance is not enough to cover the cost. The NHI is willing to continue to communicate and actively review the calculation formula of DET on the premise of ensuring the rights and interests of the public with drugs, so that the pharmaceutical industry has a reasonable living space.
However, Tsai Ming-chung believes that even if DET continues to carry out, the effect of suppressing the continuous expansion of drug costs will gradually become blunt with time. As for the cost of DET, it will become a burden for the medical sector.
# Drugs # DET # Lack of Drugs # Floor Price # Health Insurance Department

Low drug prices reduce pharmaceutical companies' production willingness, prompting a proposed "floor price" to protect their basic profits.

Taiwan sets a floor price for prescription drugs and reviews the Drug Expenses Target System.

Taiwan has 131 necessary medicines out of stock despite government efforts to maintain a stable supply.

Title:

Content: The Kuomintang group calls on Chen Chien-jen to take over the government's national security crisis
REPORTER WENG Tzu-kun / Taipei Report
The shortage of drugs in the country continues to burn, the Kuomintang Legislative Yuan group today (1) a press conference called on the Tsai government, do not just want to vote all day, more concerned about the people's health rights, if the Minister of Health and Welfare Xue Ruiyuan, the Food and Drug Administration Director Wu Xiumei do not do well, it will be cut off.
The KMT further demanded that the "Drug Deficiency Monitoring Center" be raised to the level of the Executive Yuan, and called on Premier Chen Jianren to take over the management and treat it as a national security level issue.
This is an advertisement, please continue reading.
The Kuomintang group today opened a "shortage of drugs! shortage of drugs! When?" press conference, the general convenor Zeng Mingzong said that the shortage of drugs is a structural problem, health insurance to slash the price of drugs, so that the shortage of drugs crisis expanded, local pharmaceutical companies are more reluctant to produce low-cost drugs.
And some people complained, ran 10 drug bureaus did not receive drugs, beat the table to scolding, so that the community pharmacist pressure is great.
Zeng Mingzong pointed out that, for example, muscle relaxants reported a shortage of drugs on March 8, 2021, compound antibiotics, anti-fever pain tablets reported a shortage of drugs on June 6, 2022, blood pressure drugs reported a shortage of drugs on August 25, 2022, blood lipid-lowering drugs reported a shortage of drugs on August 26, 2022. In addition to the election, Tsai's government also cares about the health of the nation's people.
Zeng Mingzong said that the Kuomintang group humbly asked the Tsai government, the current lack of eggs, water, and medicine in the country, the people are asking the government what is wrong? Impairment! Failure! Please the government to come up with a specific plan to solve the problem of shortage of drugs, and ensure the basic health rights of 23 million people.
Hsieh Ying-yi, secretary-general, says that recent shortages of amoxicillin, acetaminophen, magnesium oxide, and ibuprofen in primary pharmacies and clinics have revealed that there are 131 medicines out of stock in Taiwan.
She stressed that in order to solve the problem of drug shortage, the community pharmacy has also set up a "mutual aid association" to find drugs in the way of drug exchange.
He bluntly said that this is a serious national security problem, will it make the burden of health care more heavy?
For a long time, the total amount of health insurance system has been driving down drug prices, but international pharmaceutical companies are facing a global shortage of goods, and will not give priority to imports to Taiwan.
When the National Health Insurance Administration wants to solve the unreasonable drug price difference, does it also solve the problem of drug prices that do not meet the cost?
Xie Yifeng also pointed out that on February 11, Xue Ruiyuan urgently convened a meeting on shortage of drugs, and resolved to persuade drug manufacturers to increase production capacity. If it is not possible to increase production capacity, then strengthen the allocation of hospitals and clinics to pharmacies to solve the problem of shortage of drugs.
How does the Ministry of Health and Welfare assist domestic pharmaceutical companies in obtaining raw materials and mass-producing pharmaceutical products?
Not at all.
Shouldn ’ t the Ministry of Health and Welfare convene meetings across ministries, industries, and pharmaceuticals to coordinate and solve problems?
Hsieh Yi-hung lambasted that after the meeting of the Ministry of Health and Welfare, nothing had been done, and such a meeting would not be held.
The Ministry of Health and Welfare will increase the burden of health insurance to 120 million yuan on April 1, which is expected to affect 1.17 million people.
Please ask Chen Chien-jen and the Ministry of Health and Welfare, in the special budget after the epidemic, to allocate 20 billion yuan for health insurance, why do you need to increase part of the burden?
The Ministry of Health and Welfare should first solve the problem of lack of medicines, and do not want to spend money from the pockets of the people.
On March 29, 2019, Wu Xiumei, who is responsible for managing the national drug administration department, held a meeting on “Drug Shortage ”. The results of the expert meeting on the evaluation of the operation and follow-up mechanism of the meeting were only based on the meeting and the meeting was postponed, and the decisions made after the meeting were not implemented.
"Taiwan's lack of medicine is a problem of management." Lai Shibao pointed out that the Ministry of Health and Welfare has constantly justified itself with problems such as rising raw materials and the Russian-Ukrainian war, but the whole world is affected, and Taiwan alone has a shortage of medicine.
In 1999, the US FDA established a “Drug Deficiency Monitoring Center ”, which stipulates that any drug that is less than 6 months in stock must be monitored and taken countermeasures.
Lai Shih-pao points out that the pharmaceutical and medical sectors in Taiwan have long called on the government to do the same.
Lai Shih-pao also suggested that Chen Chien-jen, the National Health Insurance Administration (NHIA) plans to slash the health insurance drug budget by NT $8.1 billion. Please ask the so-called warm and tenacious cabinet to start caring for humanity and solve the problem of shortage of drugs as soon as possible.
In 2016, Tsai Ying-ying told pharmacists at the All-Union Congress of Pharmacists that it was necessary to make medicines available to the people and replace them with social medicines in 2018. The result was still a shortage of drugs.
Yang Qiong said that magnesium oxide mainly treats gastric and esophageal reflux and constipation, is a common chronic prescription drug. Patients need to use drugs every day. Does the government know? In addition, the first-line commonly used antibiotics Ammonicillin and acetaminophen painkillers are lacking, which increases the risk of physical collapse of first-line medical care.
The government does not know what the problem is, and even the drugs have to go back to the original "drug-for-drugs" era, the "drug-for-drugs monitoring center" must be raised to the level of the Executive Yuan, immediately inventory 131 drug categories, immediately replenish, strengthen the monitoring mechanism, so that the people really have drugs available.
Dr. Shen Caiying, spokesman of the Taiwan Pharmaceutical Marketing and Management Association, said with emotion that Tsai Ing-wen had said that the society has drugs available, and the people will use drugs, which of course is also the responsibility of pharmacists.
During the epidemic, the Ministry of Health and Welfare relied heavily on community pharmacies to issue masks and rapid screening to take on the frontline public health mission, but the Ministry of Health and Welfare seemed indifferent to the serious problem of drug shortage.
Shen Caiying questioned the government, according to Article 15 of the "National Health Insurance Drug Price Adjustment Operation Measures", the directive drug is not allowed to have a floor price, but the Director of Health Insurance Shi Chongliang publicly stated that the directive drug should be set a floor price to solve the problem of drug shortage.
Shen Caiying said that for every US dollar used in the United States on the instructions, it can save 6 to 7 US dollars for health insurance, which can save 10.2 billion US dollars a year.
Shen Caiying suggested that the government, to solve the problem of shortage of drugs, please administer according to law, instruct that drugs should not be paid, cancel the daily drug charge, and pay.
The drug shortage center must combine relevant professional groups, patient groups, and pharmaceutical industry to jointly discuss the problem of drug shortage.
In addition, one of the four vice presidents of the Executive Yuan ’ s Commission for Sustainable Development is Minister Weifu. I wonder if the Minister of Weifu has told the Executive Yuan that there is a serious shortage of drugs?
Or do you want the community pharmacy to suffer silently?
This is an advertisement, please continue reading.

The US FDA has a Drug Deficiency Monitoring Center, but Taiwan's Ministry of Health and Welfare does not.

The Kuomintang demands a "Drug Deficiency Monitoring Center" and the Minister convened a meeting on the issue.

Taiwan's health insurance system drives down drug prices, causing shortages, and the budget is planned to be slashed.

Taiwan is often prioritized last by international pharmaceutical companies due to its low prices and lack of government funding to address drug shortages.

Community pharmacies have formed a "mutual aid association" to address medication shortages, underscoring the need for government support.

The World Health Organization (WHO) promotes pharmaceutical quality and combats drug smuggling and counterfeiting to help address global medication shortages.

Title:

Content: Advertisement
LEBANON
Cooperation meeting between the World Health Organization and the President of Pharmacists to promote the pharmaceutical sector
21-09-2022 | 06: 51
A-
A +
photos 0
A +
A-
A meeting was held between the representative of the World Health Organization (WHO) in Lebanon, Dr. Abdel Nasser Mahmoud Abu Bakr, and the President of the Lebanese Pharmacists, Dr. Joe Salloum, in the presence of members of the organization.
According to the press office of the President of Pharmacists, during the meeting, "a vision was developed for the pharmaceutical sector, maintaining the quality of the drug, securing it for the disease, and ways to combat all forms of smuggling, counterfeiting and drug trafficking at the expense of the patient."
Advertisement
"A series of joint steps will be announced later in cooperation with the Ministry of Health," he said.
The meeting aims at "cooperation between the World Health Organization and the President of the Lebanese Pharmacists in order to promote the pharmaceutical sector in Lebanon and provide good medicine to the patient."
Source: National Information Agency
Go ahead.
Advertisement
Our news via your email
SIGN UP
Softimpact
All rights reserved © Lebanon24
All rights reserved © Lebanon24
Softimpact

WHO ensures drug security and cooperates with local health authorities to promote good medicine provision.

International cooperation and knowledge sharing are essential in addressing global medication shortages, as emphasized by the WHO.

Title:

Content: An expanded meeting to follow up the public tender of medicines..
And the medical supply explains the lack of blood bags.
Cairo - Center Gate Sunday 30 July 2023, 10: 15 pm
The head of the medical supply system said that the announcement of the shortage of blood bags and its request from international organizations was caused by poor coordination, pointing to the existence of sufficient quantities of this item, which were distributed to all blood banks, pointing to the waiting for a new shipment this week containing 35 thousand bags.
This came during an expanded meeting held today at the Cabinet Office of the Government of National Unity, to follow up the implementation of the public tender for medicines and medical supplies, where the Chairman of the sub-tender committee presented a detailed presentation of the latest measures taken on the second round of the public tender in a number of medicines and supplies, according to a statement published by the government page on « Facebook ».
« Medical Supply » takes action to address the shortage of blood bags in Libya
During the meeting, Al-Dabaiba issued instructions on the need to implement the public tender soon, noting that any party delayed this will contribute to the spread of corruption in this sector, stressing the need to be the mechanism of cooperation with international organizations in the field of benefiting from their expertise and technical capabilities.
The meeting was held in the presence of SAI President Khalid Shukhak, Deputy Prime Minister and Health Minister-designate Ramadan Abu Jinnah, the Ministers of Finance and State for Cabinet Affairs, the Undersecretary of the Ministry of Health, the Chairman and members of the Medical Supply Authority Management Committee, the Director of the National Center for Disease Control, and a number of directors of departments at the Ministry of Health and SAI.
An expanded meeting was held today at the Cabinet Office of the Interim Unity Government, Sunday, July 30, 2023 (Government Facebook page)
An expanded meeting was held today at the Cabinet Office of the Interim Unity Government, Sunday, July 30, 2023 (Government Facebook page)
More from the middle gate.
Related Titles
Tunisia rejects' fallacies' over migrant crisis stuck near Libya
Al-Hawij approves 16 investment projects for the private sector in different regions
40 Egyptian migrants arrested west of Sirte
See in « Economy Plus »: Libya recovers 26.4 billion dinars from companies...
See also “Here ’ s Libya: The Price of Medicines. ”
Pharmacies or Monopoly?
More...
Most preferred in this section.

The WHO warns of a global injection shortage of up to 2 billion units by next year, threatening vaccination efforts.

Title:

Content: 19: 53 GMT09 November 2021
LIVE
The world.
Copy the link
0 01
Follow us via
The World Health Organization (WHO) warned on Tuesday of the risk of a worldwide injection shortage of up to 2 billion units by next year, threatening to disrupt vaccination efforts.
The shortfall is mainly due to COVID-19 vaccination campaigns, where billions of injections are used more than usual around the world, which has negatively affected the world ’ s supply of this essential tool.
The World Health Organization ’ s senior adviser on securing access to medicines and health products, Lisa Hedman, said that as the supply of doses of the coronavirus vaccine increases, the supply of injections must be kept up.
"We are raising real concern that there may be a shortage of immunization syringes, which in turn will lead to serious problems, such as slowing down vaccination efforts."
And she went on to say:
"Depending on how the vaccine is absorbed, the deficit could range from 1 billion to 2 billion injections."
More than 7.25 billion doses of the coronavirus vaccine have been given to the global population, nearly double the number of routine vaccinations given annually and double the number of injections required, according to an AFP tally.
See also:
World Health Organization: The pace of coronavirus transmission in Europe is very worrying
WHO approves emergency use of India ’ s Covaxine anti-coronavirus vaccine
WHO resolves controversy over combined coronavirus and flu vaccines
Keywords:
Coronavirus, WHO

The COVID-19 pandemic has caused a worldwide injection shortage, with 7.25 billion coronavirus vaccine doses given globally.

The WHO addresses medicine shortages and has a plan for traditional medicine, including knowledge sharing and a global repository.

Title:

Content: General Supervision
Elham Aboul Fath
Editor-in-Chief
Thank you for your patience.
General Supervision
Elham Aboul Fath
Editor-in-Chief
Thank you for your patience.
Medication Authority Participates in the International Meeting of Global Health in India on Traditional Medicine
The Egyptian Medicines Authority announced the end of its participation in the international technical coordination meeting held in New Delhi, India, from 19 to 21 March 2024, organized by the World Center for Traditional Medicine of the World Health Organization (WHO), to follow up on the action plan set by the first World Summit on Traditional Medicine of the World Health Organization (WHO) in 2023.
The panel brought together 31 countries in six WHO regions to discuss the implementation of the WHO Plan of Action for Traditional Medicine for 2024-2025, which focused on policy review, research and evidence, knowledge sharing, digital health and traditional medicine and their applications.
In addition, participants discussed the creation of a global repository of traditional medicine as a comprehensive and useful product for global public health, which would provide access to evidence-based information and resources on traditional, complementary and integrative medicine and indigenous knowledge, review existing repositories, and define the scope, methodologies, management, and technology needed to create such a global repository.
This comes within the framework of the Egyptian Drug Authority's keenness to enhance and exchange experiences, open communication channels on an ongoing basis, and support all means of cooperation with various international and regional bodies and organizations, especially the World Health Organization.

International organizations like the WHO can provide technical expertise to countries facing shortages, as seen in Libya's blood bag shortage.

The WHO has found that twenty-eight of thirty-five countries it monitors face penicillin-type drug shortages.

Title:

Content: Experts have recorded a shortage of antibiotics in the world due to the increase in the number of infectious diseases.
On December 21, writes the Financial Times with reference to the head of the group of the World Health Organization (WHO) for the supply of medicines and ensuring access to them Lisa Hedman, reports Day.Az.
Twenty-eight of the 35 countries for which WHO collects data are deficient in penicillin-type drugs.
In the United States and Canada complained about the lack of amoxicillin.
Less is known about the situation in poor or small countries, according to Hedman.
It is noted that in addition to the difficulties experienced by pharmaceutical manufacturers in the pandemic, the current situation is complicated by high energy prices, and this leads to a decrease in profits of companies.
In addition, countries, according to Hedman, did not expect that in the first year without masks, respiratory infections would hit the population so hard.
In addition to antibiotics, pharmacists also complain about the lack of painkillers, drugs for tuberculosis and drugs for skin infections.

The WHO facilitates global cooperation to address medication shortages and provide access to healthcare services.

Title:

Content: Experts have recorded a shortage of antibiotics in the world due to the increase in the number of infectious diseases.
On December 21, writes the Financial Times with reference to the head of the group of the World Health Organization (WHO) for the supply of medicines and ensuring access to them Lisa Hedman, reports Day.Az.
Twenty-eight of the 35 countries for which WHO collects data are deficient in penicillin-type drugs.
In the United States and Canada complained about the lack of amoxicillin.
Less is known about the situation in poor or small countries, according to Hedman.
It is noted that in addition to the difficulties experienced by pharmaceutical manufacturers in the pandemic, the current situation is complicated by high energy prices, and this leads to a decrease in profits of companies.
In addition, countries, according to Hedman, did not expect that in the first year without masks, respiratory infections would hit the population so hard.
In addition to antibiotics, pharmacists also complain about the lack of painkillers, drugs for tuberculosis and drugs for skin infections.

The WHO helps countries secure health sector needs through international cooperation, as seen in Syria.

Title:

Content: The news tape.
Eng. Arnous discusses with Dr. Balkhi the strengthening of cooperation between Syria and the World Health Organization
Damascus-Sana
The Prime Minister, Eng. Hussein Arnous, discussed with the WHO Regional Director for the Eastern Mediterranean Dr. Hanan Balkhi and her accompanying delegation the strengthening of cooperation between Syria and WHO in securing the needs of the health sector, joint cooperation programs and training and qualifying medical cadres to keep up with the latest developments in international medical work and transfer expertise and technologies to the Ministry of Health cadres.
Eng. Arnous stressed that the health system is gradually recovering and will be able to overcome the difficulties it faces in cooperation with WHO and all international cooperation partners, pointing to the support provided by the government to the health sector through the rehabilitation of hospitals and health centers, supporting pharmaceutical factories to continue production and meet the needs of the local market.
The Prime Minister expressed appreciation for the efforts of the organization, which showed a lot of cooperation with the Syrian state, whether in the fight against Corona or in the earthquake file, and considered that the task of the health sector before being medical is an ethical and humanitarian task regardless of any considerations, pointing to the efforts exerted by the government to fill the shortage of advanced devices such as CT, magnetic resonator and cancer drugs.
For her part, Dr. Belkhi explained the organization ’ s plans and programs in the Middle East, which focus on scientific cooperation, training and rehabilitation, updating information and data, taking advantage of automation that helps in developing work and providing doctors with scientific expertise, in addition to programs to access treatment and services package, strengthening health care systems and finding solutions to challenges facing health.
The meeting was attended by the Minister of Health, Dr. Hassan Al-Ghobash, and the Secretary-General of the Presidency of the Council of Ministers, Dr. Qais Khodr.
Follow SANA news on Telegram https: / / t.me / SyrianArabNewsAgency
Look, too.
Two meetings chaired by Eng. Arnous on incentives in the productive economic sector and strengthening the electronic payment structure
Damascus, SANA – Today ’ s meeting chaired by Prime Minister Eng. Hussein Arnos focused on the mechanisms of dealing with …

The WHO provides training and support to national drug authorities to promote pharmaceutical sector development.

Title:

Content: INVESTMENT
The Ministry of Health announces the details of the visit of the delegation of the World Health Organization
Training on the standard procedures of laboratories according to the rules of the World Health Organization
Share the news with your friends
The Egyptian Medicines Authority (EMA) has announced the reception of the World Health Organization (WHO) delegation, which is holding an official visit to the agency this week.
The delegation ’ s program includes visiting the various headquarters of the Authority to follow up on the development of working mechanisms and procedures, as well as training on the standard procedures of laboratories in accordance with the rules of the World Health Organization, in addition to the measures taken to develop the infrastructure and develop the capabilities of control laboratories in line with the guidelines of the World Health Organization.
This came in line with the directives of the political leadership to exert priority efforts to promote the pharmaceutical sector in Egypt, its continued support for Egypt to assume a prominent international position in this important sector, obtain the latest global manufacturing technologies, deepen the localization of industry in Egypt, and Egypt ’ s Vision 2030. competition from global markets.
Read also Minister of Business Sector discusses with Moroccan Ambassador in Cairo the promotion of joint cooperation
The WHO delegation expressed its confidence in the ongoing preparations and the effort exerted by the Egyptian Drug Authority, stressing the continuation of constructive and fruitful cooperation and providing institutional support to enable the Egyptian Drug Authority to achieve its desired goals.
This comes in light of the Egyptian Drug Authority ’ s efforts to obtain international accreditations in line with international developments and regulatory procedures, and to promote the pharmaceutical sector to ensure the highest level of effective and integrated control.
ALSO READ Yasmine Fouad: Egypt is keen during its presidency « COP27 » to find partnerships to combat climate change
It is noteworthy that the Egyptian Drug Authority, in coordination with the various regulatory and security authorities, launched inspection campaigns on the pharmaceutical institutions last week to follow up the control of the pharmaceutical market, tighten control over the circulation of medicines, the validity of the use of preparations, and monitor various websites and electronic applications.
The campaigns resulted in the seizure of smuggled, counterfeit and unregistered drugs, and others listed in the drug schedules, with a financial value exceeding one million pounds.
Drug Authority: Seizure of smuggled, unregistered and anonymous medicines
The Authority ’ s pharmacy inspectors, in cooperation with the officers of the General Directorate of Supply Investigations in the governorates, were able to seize 2000 drops of unknown origin, without invoices, and seized three individuals selling medicines above the compulsory price, as well as medicines listed in the first table of the Anti-Drug Law, and others listed in the third table paragraph D, and medicines listed in the Ministerial Decree No. 172 of 2011 on the regulation and circulation of drugs affecting the psychological condition. It is estimated at 5000 bottles, and the value of seizures of more than 600 thousand pounds.
Ceramic exports jump to $228 million in 2021
Share the news with your friends
Previous News »
NEXT NEWS

International cooperation is necessary for equitable vaccine distribution and to address medication shortages, including preventing syringe reuse due to contamination risks.

Title:

Content: COVID-19 pandemic highlights global shortage of syringes
9 November 2021
Efforts to boost production of COVID-19 vaccines must be coupled with access to the needles needed to inject those vaccines – and there could be a global shortage of needles for regular immunization campaigns next year, the World Health Organization said on Tuesday.
Based on a scenario in which about seven billion people need two doses of the coronavirus vaccine between now and 2023, the U.N. health agency said a shortage of at least one billion injections “could happen ” if their manufacturing rate does not rise.
Lisa Hedman, a senior adviser at the World Health Organization ’ s Access to Medicines and Health Products division, has warned that a generation of children could miss their scheduled vaccination doses unless manufacturers find a way to make more disposable injections.
No room for shortcuts.
“When you think about how many injections are being given to respond to a pandemic, this is not a place where we can afford shortcuts, shortages or anything less than complete safety for patients and healthcare staff. ”
She told reporters in Geneva that more than 6.8 billion doses of COVID-19 vaccines are administered globally each year, nearly double the number of routine vaccinations given each year:
“Shortage of injections is unfortunately a real possibility and here are some additional figures.
"Global manufacturing capacity is around six billion per year for vaccination injections, it is quite clear that a deficit in 2022 of more than one billion could occur if we continue business as usual."
Ms Hedman explained that it is not recommended to reuse the syringes even after they have been sterilized, as harmful bacteria are still present.
She also noted that injections are particularly vulnerable to transport delays because they occupy 10 times the area of the vaccine.
The Urgent Need to Intensify Footage
Meanwhile, the heads of the International Monetary Fund (IMF), the World Bank Group, the World Health Organization (WHO) and the World Trade Organization (WTO) held a follow-up session to the high-level consultations with CEOs of leading Covid-19 vaccine manufacturers on Tuesday.
At the meeting, according to a press release, all participants agreed that more doses of the vaccine should be provided to low-income countries, where less than 2.5 percent of the population has been fully vaccinated.
The objective of the meeting was to determine how to ensure a more equitable distribution of vaccines and all participants pledged to continue working together to obtain greater clarity on donations, vaccine swaps and delivery schedules, so that the distribution of life-saving vaccines is more effective towards countries in greatest need.
The meeting of the Multilateral Leaders Task Force on COVID-19 built on the technical work carried out by multidisciplinary teams during September and October.
During the consultations, the heads of the four organizations and CEOs examined how best to address trade-related constraints; how to improve the donation process; what additional steps are needed to reach the 40 per cent vaccination target in all countries by the end of the year; and how to improve transparency and data sharing with the IMF, WHO and Multilateral Leaders Task Force vaccine supply forecasting dashboard.
This effort will require close collaboration between manufacturers, governments and the Kovacs International Initiative, on improved delivery schedules, especially for donated doses.
♦ Download the UN News app in Arabic from the Apple Store for iPhone and iPad IOS or from the Google Store for Android devices.
♦ Subscribe to email notifications.

The WHO supports countries in producing safe medicines and encourages international solidarity in research and development.

Title:

Content: 71% of the countries in the world do not have distinctive drug bodies
World Health Organization: Egypt has reached an advanced stage in medicines and vaccines
Tuesday ، 07 June 2022 03: 51 PM
Naima Al Qusair and Hoda Langer
I wrote Hope Allam.
Leave a comment and read the comments of the readers.
Dr. Naima Al-Qusair, representative of the World Health Organization in Egypt, revealed that a special session was held during the African Conference, Africa Health Excon on the role of the organization and supporting countries to produce safe and effective medicines, vaccines and medical supplies, and localization of medicines in various developing countries and African countries, with safety and how to give technical support and laws to support them.
Global Health
She explained that Egypt is the first country in the Middle East and the second African country to receive accreditation, pointing out that we are working to encourage solidarity between countries and develop research and its application in various countries, pointing out that Egypt has reached an advanced stage in medicines and vaccines, and we see a higher distinction up to the fourth degree of maturity and we wish to export medicines and medical supplies to African countries.
World Health 1
For her part, Dr. Huda Langer, Advisor at the World Health Organization (WHO) Regional Office for the Eastern Mediterranean, said that today we held a session on the role of WHO to cooperate with countries to improve drug control to provide high quality medicines. We seek to provide technology in African countries and developing countries, stressing that Egypt has become a pharmaceutical body approved by the Organization and thus its products of medicines and vaccines are recognized, and thus able to export them abroad.
Global Health 2
Leave a comment and read the comments of the readers.
No comments on the news.
Leave a comment
Your comment will appear after the review.

The WHO provides technical support and promotes international cooperation in the pharmaceutical sector.

The WHO cooperates with national drug authorities, such as Egypt's, to address global health issues.

Title:

Content: The Drug Authority receives a delegation from the World Health Organization
03: 39 PM Tuesday 16 Nov 2021
Ahmed Juma wrote:
Dr. Tamer Essam, President of the Egyptian Drug Authority, received on Tuesday the delegation of the World Health Organization (WHO) at the headquarters of the Authority in Agouza, within the framework of the Authority's efforts to cooperate with international organizations to obtain international accreditation.
The visit will take three consecutive days from 16 to 18 November, and will discuss means of cooperation and exchange of technical and scientific expertise in this regard.
During the visit, the Commission will shed light on the procedures for the examination, registration and analysis of vital preparations, and will review the efforts of the Commission during the Coronavirus epidemic in developing mechanisms to facilitate and speed the registration and analysis procedures, in addition to the efforts of the Commission in issuing emergency use licenses for several vaccines related to the Coronavirus.
She explained that the delegation inspected the recent development work in the Authority from the regulatory laboratories that have been developed, and other laboratories that have been updated, and that it has prepared a solid plan of action in light of the directives of the political leadership to obtain international accreditation in line with global developments.
This comes in light of the Authority ’ s keenness to keep abreast of recent global developments, and the development plan carried out by the Authority, which is not limited to the mechanisms and rules of work, but also includes the development of infrastructure, which included: reference laboratory, control laboratories, training halls, meeting rooms and educational classes, in line with international developments and references.
Corona...
Moment by moment.
Corona News
946.
Injuries today
68.
Deaths today
432.
Healing today.
344907.
Total Injuries
19567.
Total deaths
288114.
Total recovered
Announcement
Announcement
• Notification Service
Receive the latest news and updates from Masrawy

The WHO stresses global vaccine sharing and international cooperation to combat COVID-19 and medication shortages.

Title:

Content: WHO: Vaccines must be shared globally
HATT / NOOR SUDAN / August 7 – The World Health Organization (WHO) has stressed the need to ensure that the COVID-19 vaccine is shared globally.
WHO Director-General Tedros Adhanom Ghebreyesus, speaking at an online security forum in the United States, warned that nationalizing vaccines will not help fight the epidemic, because the world is integrated and the world can recover faster only if the global population is cured together.
He pointed out that global sharing of vaccines is in the interest of rich countries, because rich countries will not be safe if the virus is still circulating in poor countries.
Globally, the cumulative number of cases of coronary disease is approaching 19 million, of which more than 710,000 people have died.
【 Editor: Muhtar Murati 】
I'm reading.

The WHO can facilitate international cooperation in traditional medicine to promote well-being and sustainable development.

Title:

Content: People 's Network > > International
Promote traditional medicine, strengthen exchanges and mutual learning (fight the epidemic together)
Our reporter Zhang Bolan
August 02, 2021 05: 14 | Source: People's Daily - People's Daily
Small number
At the 2021 Shanghai Cooperation Organization Forum on Traditional Medicine held in Nanchang, Jiangxi Province, guests from all over the world attended the forum on the theme of “inheritance, innovation, mutual learning and sharing ” through online and offline participation to discuss the development of traditional medicine and build a human health community, providing support for the SCO countries to bring the unique advantages of traditional medicine into play and fight against the epidemic.
The Deputy Director-General of the World Health Organization, Suzanne Jacobs, called for the establishment of a comprehensive coordination mechanism, comprehensive information exchange and cooperation platform, so that different countries can strengthen cooperation in the field of traditional medicine, so as to further promote the well-being of people and the sustainable development of mankind.
Kazakhstan Deputy Minister of Health Geniat Azar said: “The SCO countries have shown the spirit of solidarity in fighting the epidemic, cooperation and mutual benefit. ” Afghan Ambassador to China Khaim suggested that SCO member states establish research centers for traditional medicine to jointly carry out research and development, so that the results of cooperation can be faster and more widely beneficial to people around the world.
First Deputy Prime Minister of the Republic of Belarus Snopkov said that traditional Chinese medicine is a fusion of experience and innovation, which has received the attention of more and more countries and people.
Chinese medicine has played an important role in the anti-epidemic assistance provided by China to Belarus, and has shown unique results.
Armenian Ambassador to China Manasaryan said: "Chinese medicine has always been very popular in our country.
During the epidemic prevention and control period, the treatment of patients in combination with the traditional Chinese medicine method has been very effective, and the demand for traditional Chinese medicine has become even greater.
Tajik Ambassador to China Saeed Zoda said that strengthening cooperation in the field of public health through the traditional medical forum has become an important complement to bilateral cooperation.
The two countries have worked closely in unity and cooperation, strengthened the exchange of experience and sharing of achievements in traditional medicine, and jointly committed themselves to implementing the concept of a community with a shared future for mankind.
Kyrgyz Deputy Prime Minister Mikhail Bakashova said that traditional medical treatments could further enrich the existing medical systems of the SCO member states.
The forum will promote exchanges and mutual learning of advanced experience and knowledge, and further bring into play the role of Oriental Medicine in fighting the epidemic.
People 's Daily (August 02, 2021 06 edition)
(Edited by: Niu Yong, Yuan Bo)
Share it so more people can see it.
Back to top

The Ministry of Health and Welfare created a center to monitor and respond to drug shortages in real-time.

Title:

Content: This website uses relevant technologies to provide a better reading experience, while respecting the privacy of users. Click here to understand the privacy statement of the Central News Agency. When you close this window, you agree to the above regulations.
Your browser does not appear to support Traditional Chinese.
Would you like to go to CNA ’ s English website, “Focus Taiwan ”?
Koko Koko Koko Koko Koko Koko
"日本語版「フィーカス」について" (in Japanese).
Central News First-hand News APP
Download
Chinese medicine shortage for the first time, the Ministry of Health and Welfare announced the new system as soon as April
2023 / 3 / 12 12: 14 (Updated 3 / 12 12: 52)
Please agree to our privacy policy in order to enable news listening.
The Ministry of Health and Welfare has organized a drug shortage prevention center to bring the drug shortage treatment mode to the ministerial level.
Minister of Health and Welfare Xue Ruiyuan said on the 12th that the plan is to officially report the shortage of Chinese medicine for the first time.
Please agree to our privacy policy in order to enable news listening.
The Ministry of Health and Welfare plans to organize a drug shortage prevention center to pull the drug shortage treatment mode to the ministerial level, Minister Xue Ruiyuan said today, planning to officially report the shortage of Chinese medicine for the first time, so as to facilitate the central government to immediately respond to the dispatch, the new system is expected to hit the road as soon as April.
This morning, Xue Ruiyuan attended the National Federation of Traditional Chinese Medicine of the Republic of China 2023 93rd National Medical Day 15th Taipei International Traditional Chinese Medicine Academic Forum. In his speech, he said that in the future, Chinese medicine shortage also needs to be reported, so as to achieve real-time control, immediate response, schedule import or coordinate with manufacturers to increase production.
Hsueh Jui-yuan says that in the past, there was no clear mention of Chinese medicine in the Pharmacy Act, because in the past it was mainly handled by the Food and Drug Administration, and the scope would be narrower, mainly targeting Western medicine shortages, but this time the Coordination Center for Chinese medicine shortage notification was brought to the ministerial level, so Chinese medicine shortages were also brought in.
Xue Ruiyuan said that in the future, Chinese medicine practitioners and the Chinese medicine community as long as they find a shortage of drugs, they can report it, and today officially announced the new system, which was originally in operation, and now needs to be added to the system to report the shortage of Chinese medicine.
In addition, Xue Ruiyuan said that the Chinese medicine supply chain is also an issue that Taiwan needs to review, from raw materials to final pharmaceutical products. He hopes to cooperate with the Council of Agriculture and the Ministry of Economic Affairs to establish more domestic production supply chains. Built within 2 years. (Editor: Chen Renhua) 1120312
Recently, Western medicine shortage frequently, the Ministry of Health and Welfare organized a drug shortage prevention center, will be the lack of drug treatment mode to the ministerial level, Minister of Health and Welfare Xue Ruiyuan (middle) said on the 12th, planning for the first time to officially report the lack of Chinese medicine, is expected to be on the road as soon as April.
Photo by Chen Jiling, Central News Agency, March 12, 112
Central News Agency "First-hand News" app
The text, pictures and audio and video of this website shall not be reproduced, broadcast or transmitted or used without authorization.

The Ministry of Health and Welfare will establish domestic production supply chains, aided by a reporting system for drug shortages to be operational by April 2023.

A dedicated person and a drug price adjustment mechanism with alternative lower-cost drugs are available to help with unmet prescription costs.

A dedicated person and a drug price adjustment mechanism with alternative lower-cost drugs are available to help with unmet prescription costs.